Neurological & Cognitive Support Studies show glutathione may support brain health by reducing neuroinflammation and protecting against oxidative damagebeneficial for patients dealing with brain fog, memory issues, or neurodegenerative conditions
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has emerged as a powerful tool for reducing sleep apnea severity through sustained weight loss and metabolic improvements that benefit breathing function
The most common typically strongest in the first 48 weeks as the body adapts include: Nausea (most common, usually dose-dependent) Diarrhoea or constipation Fatigue , especially during dose escalations Mild headache Reflux and acid reflux Loss of appetite (this is the therapeutic effect, not a side effect, but it can be uncomfortable) Less common but more serious effects warranting immediate physician review include pancreatitis, gallbladder disease, and kidney issues, particularly in patients with pre-existing conditions
You already know you tolerate IV therapy well
F.FergusonE
What results can I expect and how quickly
